Sensing of damaged or dying cells by NLRP6 and NLRP3 inflammasomes has lately been hypothesized to prevent CRC through maintaining the balance between IL-22 and IL-22 binding protein (IL22-BP) (219). The gene discussed is IL22RA2; the disease is colorectal carcinoma.